Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
OTC (Over-the-Counter) headache medicines are medications that can be purchased without a prescription to provide relief from headaches. These medicines are widely available in pharmacies, drugstores, and other retail outlets. Common medicines include Aspirin, Acetaminophen, Naproxenand and Ibuprofen, etc.
Global OTC Headache Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Headache Medicine market research.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Headache Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
By Region
The OTC Headache Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Headache Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Others
1.3 Market by Application
1.3.1 Global OTC Headache Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Stores
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Headache Medicine Market Perspective (2018-2029)
2.2 OTC Headache Medicine Growth Trends by Region
2.2.1 Global OTC Headache Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Headache Medicine Historic Market Size by Region (2018-2023)
2.2.3 OTC Headache Medicine Forecasted Market Size by Region (2024-2029)
2.3 OTC Headache Medicine Market Dynamics
2.3.1 OTC Headache Medicine Industry Trends
2.3.2 OTC Headache Medicine Market Drivers
2.3.3 OTC Headache Medicine Market Challenges
2.3.4 OTC Headache Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Headache Medicine Players by Revenue
3.1.1 Global Top OTC Headache Medicine Players by Revenue (2018-2023)
3.1.2 Global OTC Headache Medicine Revenue Market Share by Players (2018-2023)
3.2 Global OTC Headache Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Headache Medicine Revenue
3.4 Global OTC Headache Medicine Market Concentration Ratio
3.4.1 Global OTC Headache Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Headache Medicine Revenue in 2022
3.5 OTC Headache Medicine Key Players Head office and Area Served
3.6 Key Players OTC Headache Medicine Product Solution and Service
3.7 Date of Enter into OTC Headache Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Headache Medicine Breakdown Data by Type
4.1 Global OTC Headache Medicine Historic Market Size by Type (2018-2023)
4.2 Global OTC Headache Medicine Forecasted Market Size by Type (2024-2029)
5 OTC Headache Medicine Breakdown Data by Application
5.1 Global OTC Headache Medicine Historic Market Size by Application (2018-2023)
5.2 Global OTC Headache Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Headache Medicine Market Size (2018-2029)
6.2 North America OTC Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Headache Medicine Market Size by Country (2018-2023)
6.4 North America OTC Headache Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Headache Medicine Market Size (2018-2029)
7.2 Europe OTC Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Headache Medicine Market Size by Country (2018-2023)
7.4 Europe OTC Headache Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Headache Medicine Market Size (2018-2029)
8.2 Asia-Pacific OTC Headache Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Headache Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Headache Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Headache Medicine Market Size (2018-2029)
9.2 Latin America OTC Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Headache Medicine Market Size by Country (2018-2023)
9.4 Latin America OTC Headache Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Headache Medicine Market Size (2018-2029)
10.2 Middle East & Africa OTC Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Headache Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Headache Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson OTC Headache Medicine Introduction
11.1.4 Johnson & Johnson Revenue in OTC Headache Medicine Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK OTC Headache Medicine Introduction
11.2.4 GSK Revenue in OTC Headache Medicine Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer OTC Headache Medicine Introduction
11.3.4 Bayer Revenue in OTC Headache Medicine Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Haleon
11.4.1 Haleon Company Detail
11.4.2 Haleon Business Overview
11.4.3 Haleon OTC Headache Medicine Introduction
11.4.4 Haleon Revenue in OTC Headache Medicine Business (2018-2023)
11.4.5 Haleon Recent Development
11.5 Tongde Pharmacy
11.5.1 Tongde Pharmacy Company Detail
11.5.2 Tongde Pharmacy Business Overview
11.5.3 Tongde Pharmacy OTC Headache Medicine Introduction
11.5.4 Tongde Pharmacy Revenue in OTC Headache Medicine Business (2018-2023)
11.5.5 Tongde Pharmacy Recent Development
11.6 Huazhong Pharmaceutical
11.6.1 Huazhong Pharmaceutical Company Detail
11.6.2 Huazhong Pharmaceutical Business Overview
11.6.3 Huazhong Pharmaceutical OTC Headache Medicine Introduction
11.6.4 Huazhong Pharmaceutical Revenue in OTC Headache Medicine Business (2018-2023)
11.6.5 Huazhong Pharmaceutical Recent Development
11.7 Weisen Pharmaceutical
11.7.1 Weisen Pharmaceutical Company Detail
11.7.2 Weisen Pharmaceutical Business Overview
11.7.3 Weisen Pharmaceutical OTC Headache Medicine Introduction
11.7.4 Weisen Pharmaceutical Revenue in OTC Headache Medicine Business (2018-2023)
11.7.5 Weisen Pharmaceutical Recent Development
11.8 DIAO GROUP
11.8.1 DIAO GROUP Company Detail
11.8.2 DIAO GROUP Business Overview
11.8.3 DIAO GROUP OTC Headache Medicine Introduction
11.8.4 DIAO GROUP Revenue in OTC Headache Medicine Business (2018-2023)
11.8.5 DIAO GROUP Recent Development
11.9 Jiheng Pharmaceutical
11.9.1 Jiheng Pharmaceutical Company Detail
11.9.2 Jiheng Pharmaceutical Business Overview
11.9.3 Jiheng Pharmaceutical OTC Headache Medicine Introduction
11.9.4 Jiheng Pharmaceutical Revenue in OTC Headache Medicine Business (2018-2023)
11.9.5 Jiheng Pharmaceutical Recent Development
11.10 Dirui Pharmaceutical
11.10.1 Dirui Pharmaceutical Company Detail
11.10.2 Dirui Pharmaceutical Business Overview
11.10.3 Dirui Pharmaceutical OTC Headache Medicine Introduction
11.10.4 Dirui Pharmaceutical Revenue in OTC Headache Medicine Business (2018-2023)
11.10.5 Dirui Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research